InfuSystem (INFU): AWM reports 2.8% stake, 561,656 shares
InfuSystem Holdings (INFU): AWM Investment Company filed Amendment No. 11 to Schedule 13G reporting beneficial ownership of 561,656 shares of InfuSystem common stock, representing 2.8% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
InfuSystem Holdings (INFU): AWM Investment Company filed Amendment No. 11 to Schedule 13G reporting beneficial ownership of 561,656 shares of InfuSystem common stock, representing 2.8% of the class.
AWM reports sole voting and sole dispositive power over these shares. The filing states AWM acts as investment adviser to Special Situations Life Sciences Fund, L.P., which holds the shares. The certification indicates the securities were acquired and are held in the ordinary course of business and not to change or influence control. Item 5 confirms ownership of 5 percent or less of the class. The date of the event requiring the filing is 09/30/2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in INFU does AWM Investment Company report?
Is AWM’s INFU stake passive or active?
What is the date of the reportable event for AWM’s INFU filing?
What is AWM’s filer classification in this 13G/A?
Does AWM own more than 5% of INFU?
Who signed the filing and when?
AI-generated analysis. How Rhea-AI works. Not financial advice.